You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
Br J Cardiol 2012;19:65–9 10.5837/bjc.2012.013
Patient knowledge and understanding of their condition is important in every field of medicine. It is particularly relevant in cardiology where choices between treatment options
Br J Cardiol 2012;19:71–5 10.5837/bjc.2012.014
We previously reported retrospective data on the place of death for people with heart failure (HF) known to heart failure nurse specialists (HFNS) working in
Br J Cardiol 2012;19:76–8 10.5837/bjc.2012.015
To see whether a nurse-led clinic might be useful we audited how often patients discharged from follow-up were elsewhere seen in the community and how
Br J Cardiol 2012;19:79–84 10.5837/bjc.2012.016
With conflicting findings from studies of omega-3 fatty acids in cardiovascular disease, many healthcare professionals are uncertain of whether they show any benefit. BJC seminars
Br J Cardiol 2012;19:85–9 10.5837/bjc.2012.017
Up to one-third of patients with heart disease have diabetes. Cardiological status should be considered when deciding on treatment for diabetes. Patients with stable coronary
Br J Cardiol 2012;19:90–4 10.5837/bjc.2012.018
Pacemakers are being implanted with increasing frequency. As with every procedure, there is the potential for complications. There are little recent data on implant complications
Br J Cardiol 2012;19:95–6 10.5837/bjc.2012.019
We present a case of a 55-year-old female with a successfully reperfused myocardial infarction in whom Dressler’s syndrome was subsequently diagnosed. There have been no
Br J Cardiol 2012;19:21–3 10.5837/bjc.2012.001
The importance of heart rate reduction in chronic stable heart failure (HF) has been highlighted in the recently published Systolic Heart Failure Treatment with If
Br J Cardiol 2012;19:24 10.5837/bjc.2012.003
Br J Cardiol 2012;19:25 10.5837/bjc.2012.004
Although morbidity and mortality are the most commonly used end points in clinical trials of heart failure treatments, it is also important to consider how
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
You need to be a member to download PDF's.
Sign up for free membership, or log in.
Find out more about our membership benefits